Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication
ABSTRACTThe second human pegivirus HPgV-2 is a novel blood-borne virus that is strongly associated with the hepatitis C virus (HCV) infection. However, the molecular evidence for their association as well as the natural history and tissue tropism of HPgV-2 remain to be elucidated. In this longitudin...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1730247 |
_version_ | 1797265820048424960 |
---|---|
author | Zhengwei Wan Junwei Liu Fengyu Hu Jingwei Shui Linghua Li Haiying Wang Xiaoping Tang Chengguang Hu Yuanhao Liang Yuanping Zhou Weiping Cai Shixing Tang |
author_facet | Zhengwei Wan Junwei Liu Fengyu Hu Jingwei Shui Linghua Li Haiying Wang Xiaoping Tang Chengguang Hu Yuanhao Liang Yuanping Zhou Weiping Cai Shixing Tang |
author_sort | Zhengwei Wan |
collection | DOAJ |
description | ABSTRACTThe second human pegivirus HPgV-2 is a novel blood-borne virus that is strongly associated with the hepatitis C virus (HCV) infection. However, the molecular evidence for their association as well as the natural history and tissue tropism of HPgV-2 remain to be elucidated. In this longitudinal study, a total of 753 patients including 512 HIV-1 and HCV co-infected patients were enrolled to characterize the natural history of HPgV-2 infection. Peripheral blood mononuclear cells (PBMCs) and liver biopsies were collected to determine the tissue tropism of HPgV-2 using immunohistochemical staining of the HPgV-2 antigen and in situ hybridization of HPgV-2 RNA. We documented both persistent HPgV-2 infection with the presence of HPgV-2 viral RNA and antibodies up to 4.6 years and resolved HPgV-2 infection, accompanied by a simultaneous decline of anti-HPgV-2 antibodies and clearance of HPgV-2 viremia. Furthermore, we observed the clearance of HCV, but not HPgV-2, by treatment with direct-acting antivirals (DAAs). Biochemical tests and pathological analyses did not reveal any indication of hepatic impairment caused by HPgV-2. HPgV-2 RNA and nonstructural antigen were detected in the lymphocytes, but not in the hepatocytes present in the liver biopsy samples. In addition, both positive- and negative-strand HPgV-2 RNAs were detected in PBMCs, especially in B cells. The present study is the first to provide evidence that HPgV-2 is a lymphotropic, but not a hepatotropic virus and that HPgV-2 replication is independent of HCV viremia. These new findings let us gain insights into the evolution and persistent infection of RNA viruses in humans. |
first_indexed | 2024-03-07T17:24:16Z |
format | Article |
id | doaj.art-ac8a13771648486baab3b4596cb35260 |
institution | Directory Open Access Journal |
issn | 2222-1751 |
language | English |
last_indexed | 2024-04-25T00:50:52Z |
publishDate | 2020-01-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Emerging Microbes and Infections |
spelling | doaj.art-ac8a13771648486baab3b4596cb352602024-03-11T16:04:25ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-019148549510.1080/22221751.2020.1730247Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replicationZhengwei Wan0Junwei Liu1Fengyu Hu2Jingwei Shui3Linghua Li4Haiying Wang5Xiaoping Tang6Chengguang Hu7Yuanhao Liang8Yuanping Zhou9Weiping Cai10Shixing Tang11Department of Epidemiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of ChinaDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of ChinaInfectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Epidemiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of ChinaInfectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Epidemiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of ChinaInfectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of ChinaDepartment of Epidemiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of ChinaDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of ChinaInfectious Disease Center, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Epidemiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of ChinaABSTRACTThe second human pegivirus HPgV-2 is a novel blood-borne virus that is strongly associated with the hepatitis C virus (HCV) infection. However, the molecular evidence for their association as well as the natural history and tissue tropism of HPgV-2 remain to be elucidated. In this longitudinal study, a total of 753 patients including 512 HIV-1 and HCV co-infected patients were enrolled to characterize the natural history of HPgV-2 infection. Peripheral blood mononuclear cells (PBMCs) and liver biopsies were collected to determine the tissue tropism of HPgV-2 using immunohistochemical staining of the HPgV-2 antigen and in situ hybridization of HPgV-2 RNA. We documented both persistent HPgV-2 infection with the presence of HPgV-2 viral RNA and antibodies up to 4.6 years and resolved HPgV-2 infection, accompanied by a simultaneous decline of anti-HPgV-2 antibodies and clearance of HPgV-2 viremia. Furthermore, we observed the clearance of HCV, but not HPgV-2, by treatment with direct-acting antivirals (DAAs). Biochemical tests and pathological analyses did not reveal any indication of hepatic impairment caused by HPgV-2. HPgV-2 RNA and nonstructural antigen were detected in the lymphocytes, but not in the hepatocytes present in the liver biopsy samples. In addition, both positive- and negative-strand HPgV-2 RNAs were detected in PBMCs, especially in B cells. The present study is the first to provide evidence that HPgV-2 is a lymphotropic, but not a hepatotropic virus and that HPgV-2 replication is independent of HCV viremia. These new findings let us gain insights into the evolution and persistent infection of RNA viruses in humans.https://www.tandfonline.com/doi/10.1080/22221751.2020.1730247HPgV-2persistent infectionresolved infectionlymphotropicHCV |
spellingShingle | Zhengwei Wan Junwei Liu Fengyu Hu Jingwei Shui Linghua Li Haiying Wang Xiaoping Tang Chengguang Hu Yuanhao Liang Yuanping Zhou Weiping Cai Shixing Tang Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication Emerging Microbes and Infections HPgV-2 persistent infection resolved infection lymphotropic HCV |
title | Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication |
title_full | Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication |
title_fullStr | Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication |
title_full_unstemmed | Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication |
title_short | Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication |
title_sort | evidence that the second human pegivirus hpgv 2 is primarily a lymphotropic virus and can replicate independent of hcv replication |
topic | HPgV-2 persistent infection resolved infection lymphotropic HCV |
url | https://www.tandfonline.com/doi/10.1080/22221751.2020.1730247 |
work_keys_str_mv | AT zhengweiwan evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT junweiliu evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT fengyuhu evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT jingweishui evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT linghuali evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT haiyingwang evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT xiaopingtang evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT chengguanghu evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT yuanhaoliang evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT yuanpingzhou evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT weipingcai evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication AT shixingtang evidencethatthesecondhumanpegivirushpgv2isprimarilyalymphotropicvirusandcanreplicateindependentofhcvreplication |